THE EVERY COMPANY BUSINESS MODEL CANVAS TEMPLATE RESEARCH
EVERY Company Business Model Canvas: Ready-to-Use Playbook for Investors & Founders
Unlock The EVERY Company's strategic playbook with our full Business Model Canvas-concise, actionable, and ready to use in Word or Excel; perfect for investors, founders, and consultants who want to see how value creation, revenue streams, and partnerships drive growth.
Partnerships
AB InBev BioBrew global manufacturing scale-up agreement
AB InBev BioBrew gives The EVERY Company access to >100,000 L+ industrial bioreactors, removing a key capacity bottleneck and avoiding an estimated $500M-$1B in capex for greenfield fermentation plants.
That lets EVERY scale from pilot to multi-ton annual production within 12-18 months to meet global CPG demand, supporting projected 2025 revenue targets and faster commercial rollouts.
Ingredion exclusive global distribution and sales partnership
Ingredion serves as EVERY Company's exclusive global commercial partner, deploying its 2025 sales network of ~3,800 direct reps and relationships with 7,500+ food manufacturers to scale EVERY's products; Ingredion reported $8.6B net sales in FY2025, which accelerates EVERY's market reach and shortens sales cycles.
This partnership leverages Ingredion's ingredient-application labs and regulatory teams-reducing EVERY's go-to-market development by an estimated 40% and enabling plug-and-play adoption across Ingredion's global supply chain in 60+ countries.
Grupo Bimbo strategic investment and product integration
Grupo Bimbo's 2025 pilot supplies a guaranteed high-volume customer: Bimbo's global 2024 revenue was $20.8B and it bakes ~13 billion units daily, offering a real-world testbed to replace egg whites in commercial lines and cut Scope 3 emissions tied to egg sourcing.
Alpha Foods co-branding and product development alliance
EVERY Company partners with Alpha Foods to co-develop meat alternatives using EVERY's animal-free egg proteins, improving texture and +20-35% protein retention vs pea isolates and targeting the 48% of US consumers who identify as flexitarian (2025 Mintel).
- Boosts sensory appeal: +15% higher taste scores in pilot panels (Q3 2025)
- Price premium: supports 10-15% higher SRP in premium vegan segment
- Brand halo: Alpha distribution expands EVERY's retail reach to ~6,500 stores (2025)
Global food safety and regulatory consulting consortiums
Global food safety and regulatory consulting consortiums help EVERY Company maintain GRAS (US) and secure EFSA (EU) approvals, enabling ongoing compliance for recombinant proteins from yeast fermentation and reducing approval times by up to 30% versus solo filings.
These partnerships sustain investor confidence and market access in 2026-supporting projected revenue runway of $48M and preserving valuation multiples tied to regulatory clearance.
- Maintain GRAS and EFSA approvals
- Reduce approval time ~30%
- Protect 2026 revenue runway $48M
- Preserve investor confidence and valuation
Strategic partners fast-track EVERY to $48M 2026 runway-capacity, sales, taste, approvals
Key partners (AB InBev BioBrew, Ingredion, Grupo Bimbo, Alpha Foods, regulatory consortia) provide capacity (>100k L reactors), sales reach (3,800 reps; Ingredion $8.6B FY2025), guaranteed demand (Bimbo $20.8B), sensory gains (+15%), and shorten approvals ~30%, underpinning EVERY's $48M 2026 revenue runway.
| Partner | 2025 Metric | Impact |
|---|---|---|
| AB InBev BioBrew | >100k L reactors | Avoids $500M-$1B capex |
| Ingredion | $8.6B sales; 3,800 reps | Speeds GTM |
| Grupo Bimbo | $20.8B revenue | High-volume pilot |
| Alpha Foods | ~6,500 stores | +15% taste; +20-35% protein |
| Regulatory consortia | ~30% faster approvals | Protects $48M 2026 runway |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for The EVERY Company detailing customer segments, value propositions, channels, revenue streams, key resources, partners, activities, cost structure, and metrics tied to competitive advantages and SWOT insights.
Customizable Excel Spreadsheet
High-level, editable Business Model Canvas that distills The EVERY Company into a one-page pain-point reliever-quickly map customer needs, revenue streams, and distribution to accelerate strategy, fundraising, or board-level decisions.
Activities
Precision fermentation strain optimization and yeast engineering
The EVERY Company continuously engineers yeast to raise protein titers-moving from ~15 g/L in 2023 toward >35 g/L targets in 2025-because each 1 g/L titer gain cuts COGS per kg by ~1.5-2.0%, a necessary path to match commodity egg prices around $2.00-$2.50/kg. In 2026 the R&D pivots to next‑gen strains that convert low‑cost carbon streams (e.g., glycerol, industrial sugars) with 20-30% higher carbon efficiency to lower feedstock costs and push breakeven volumes down.
Industrial scale-up and downstream processing management
EVERY Company oversees filtration, chromatography and spray-drying at partners to move protein from fermenter to shelf-stable powder, targeting >95% purity and <2% moisture to preserve functionality.
In 2025 EVERY audited 6 partner sites, cutting batch variance by 28% and supporting annual capacity of 1,200 tonnes of finished protein for drop-in food applications.
Regulatory filing and international compliance monitoring
The EVERY Company must update safety dossiers continuously to enter markets like Singapore, the EU, and the UK, requiring toxicology studies (GLP) costing ~USD 2-5M per compound and lifecycle environmental impact assessments per EU REACH/UK REACH standards; regulatory timelines average 12-36 months. Successful approvals create a durable moat, as median biotech seed rounds of ~USD 6M (2025) leave smaller startups unable to fund these ~USD 3-10M regulatory programs.
B2B brand positioning and ingredient marketing
EVERY Company spends ~12% of 2025 revenue on marketing and partner enablement, pushing "Powered by EVERY" ingredient branding to CPGs to drive consumer pull-through for animal-free protein.
They train CPG teams on label messaging, sustainability claims, and proof points; pilots with 8 CPG partners in 2025 showed average SKU sales lifts of 18% where the logo appeared.
- 12% of 2025 revenue on marketing/enablement
- 8 CPG pilots in 2025
- 18% average SKU sales lift with logo
- Goal: measurable consumer pull-through
Supply chain diversification and feedstock sourcing
Supply-chain diversification requires Every Company to secure carbon-neutral or circular sugars-e.g., 2025 targets: 60% certified non-GMO corn/sugar beet contracts to cut feedstock cost volatility; negotiated 5‑7 year offtakes lock average input price within ±8% vs spot.
Managing upstream inputs now equals fermentation tech for margin stability: feedstock is ~28% of COGS (2025 estimate), so long-term sourcing reduces EBITDA swing and supports predictable gross margin.
- 2025 target: 60% non-GMO, carbon-neutral feedstock
- Contract length: 5-7 years to cap volatility ±8%
- Feedstock share: ~28% of COGS (2025 estimate)
- Priority: diversify suppliers across 3+ regions
2025: >35 g/L titers, 1,200 t/yr capacity, 60% carbon‑neutral feedstock, 12% marketing
EVERY Company advances yeast titers to >35 g/L by 2025 (each 1 g/L ≈1.7% COGS/kg reduction), operates partner DSP to >95% purity, audited 6 sites supporting 1,200 t/yr, spends 12% of 2025 revenue on marketing, secured 60% carbon-neutral feedstock (5-7yr contracts), feedstock ≈28% of COGS.
| Metric | 2025 Value |
|---|---|
| Target titer | >35 g/L |
| Audited partner sites | 6 |
| Finished capacity | 1,200 t/yr |
| Marketing spend | 12% rev |
| Feedstock mix | 60% carbon-neutral |
| Feedstock share of COGS | ≈28% |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual EVERY Company Business Model Canvas-not a mockup or sample-and it's exactly the same file you'll receive after purchase.
When you complete your order, you'll instantly get this full, ready-to-edit document in Word and Excel formats, structured and formatted exactly as shown.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
EVERY Company Business Model Canvas: Ready-to-Use Playbook for Investors & Founders
Unlock The EVERY Company's strategic playbook with our full Business Model Canvas-concise, actionable, and ready to use in Word or Excel; perfect for investors, founders, and consultants who want to see how value creation, revenue streams, and partnerships drive growth.
Partnerships
AB InBev BioBrew global manufacturing scale-up agreement
AB InBev BioBrew gives The EVERY Company access to >100,000 L+ industrial bioreactors, removing a key capacity bottleneck and avoiding an estimated $500M-$1B in capex for greenfield fermentation plants.
That lets EVERY scale from pilot to multi-ton annual production within 12-18 months to meet global CPG demand, supporting projected 2025 revenue targets and faster commercial rollouts.
Ingredion exclusive global distribution and sales partnership
Ingredion serves as EVERY Company's exclusive global commercial partner, deploying its 2025 sales network of ~3,800 direct reps and relationships with 7,500+ food manufacturers to scale EVERY's products; Ingredion reported $8.6B net sales in FY2025, which accelerates EVERY's market reach and shortens sales cycles.
This partnership leverages Ingredion's ingredient-application labs and regulatory teams-reducing EVERY's go-to-market development by an estimated 40% and enabling plug-and-play adoption across Ingredion's global supply chain in 60+ countries.
Grupo Bimbo strategic investment and product integration
Grupo Bimbo's 2025 pilot supplies a guaranteed high-volume customer: Bimbo's global 2024 revenue was $20.8B and it bakes ~13 billion units daily, offering a real-world testbed to replace egg whites in commercial lines and cut Scope 3 emissions tied to egg sourcing.
Alpha Foods co-branding and product development alliance
EVERY Company partners with Alpha Foods to co-develop meat alternatives using EVERY's animal-free egg proteins, improving texture and +20-35% protein retention vs pea isolates and targeting the 48% of US consumers who identify as flexitarian (2025 Mintel).
- Boosts sensory appeal: +15% higher taste scores in pilot panels (Q3 2025)
- Price premium: supports 10-15% higher SRP in premium vegan segment
- Brand halo: Alpha distribution expands EVERY's retail reach to ~6,500 stores (2025)
Global food safety and regulatory consulting consortiums
Global food safety and regulatory consulting consortiums help EVERY Company maintain GRAS (US) and secure EFSA (EU) approvals, enabling ongoing compliance for recombinant proteins from yeast fermentation and reducing approval times by up to 30% versus solo filings.
These partnerships sustain investor confidence and market access in 2026-supporting projected revenue runway of $48M and preserving valuation multiples tied to regulatory clearance.
- Maintain GRAS and EFSA approvals
- Reduce approval time ~30%
- Protect 2026 revenue runway $48M
- Preserve investor confidence and valuation
Strategic partners fast-track EVERY to $48M 2026 runway-capacity, sales, taste, approvals
Key partners (AB InBev BioBrew, Ingredion, Grupo Bimbo, Alpha Foods, regulatory consortia) provide capacity (>100k L reactors), sales reach (3,800 reps; Ingredion $8.6B FY2025), guaranteed demand (Bimbo $20.8B), sensory gains (+15%), and shorten approvals ~30%, underpinning EVERY's $48M 2026 revenue runway.
| Partner | 2025 Metric | Impact |
|---|---|---|
| AB InBev BioBrew | >100k L reactors | Avoids $500M-$1B capex |
| Ingredion | $8.6B sales; 3,800 reps | Speeds GTM |
| Grupo Bimbo | $20.8B revenue | High-volume pilot |
| Alpha Foods | ~6,500 stores | +15% taste; +20-35% protein |
| Regulatory consortia | ~30% faster approvals | Protects $48M 2026 runway |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for The EVERY Company detailing customer segments, value propositions, channels, revenue streams, key resources, partners, activities, cost structure, and metrics tied to competitive advantages and SWOT insights.
Customizable Excel Spreadsheet
High-level, editable Business Model Canvas that distills The EVERY Company into a one-page pain-point reliever-quickly map customer needs, revenue streams, and distribution to accelerate strategy, fundraising, or board-level decisions.
Activities
Precision fermentation strain optimization and yeast engineering
The EVERY Company continuously engineers yeast to raise protein titers-moving from ~15 g/L in 2023 toward >35 g/L targets in 2025-because each 1 g/L titer gain cuts COGS per kg by ~1.5-2.0%, a necessary path to match commodity egg prices around $2.00-$2.50/kg. In 2026 the R&D pivots to next‑gen strains that convert low‑cost carbon streams (e.g., glycerol, industrial sugars) with 20-30% higher carbon efficiency to lower feedstock costs and push breakeven volumes down.
Industrial scale-up and downstream processing management
EVERY Company oversees filtration, chromatography and spray-drying at partners to move protein from fermenter to shelf-stable powder, targeting >95% purity and <2% moisture to preserve functionality.
In 2025 EVERY audited 6 partner sites, cutting batch variance by 28% and supporting annual capacity of 1,200 tonnes of finished protein for drop-in food applications.
Regulatory filing and international compliance monitoring
The EVERY Company must update safety dossiers continuously to enter markets like Singapore, the EU, and the UK, requiring toxicology studies (GLP) costing ~USD 2-5M per compound and lifecycle environmental impact assessments per EU REACH/UK REACH standards; regulatory timelines average 12-36 months. Successful approvals create a durable moat, as median biotech seed rounds of ~USD 6M (2025) leave smaller startups unable to fund these ~USD 3-10M regulatory programs.
B2B brand positioning and ingredient marketing
EVERY Company spends ~12% of 2025 revenue on marketing and partner enablement, pushing "Powered by EVERY" ingredient branding to CPGs to drive consumer pull-through for animal-free protein.
They train CPG teams on label messaging, sustainability claims, and proof points; pilots with 8 CPG partners in 2025 showed average SKU sales lifts of 18% where the logo appeared.
- 12% of 2025 revenue on marketing/enablement
- 8 CPG pilots in 2025
- 18% average SKU sales lift with logo
- Goal: measurable consumer pull-through
Supply chain diversification and feedstock sourcing
Supply-chain diversification requires Every Company to secure carbon-neutral or circular sugars-e.g., 2025 targets: 60% certified non-GMO corn/sugar beet contracts to cut feedstock cost volatility; negotiated 5‑7 year offtakes lock average input price within ±8% vs spot.
Managing upstream inputs now equals fermentation tech for margin stability: feedstock is ~28% of COGS (2025 estimate), so long-term sourcing reduces EBITDA swing and supports predictable gross margin.
- 2025 target: 60% non-GMO, carbon-neutral feedstock
- Contract length: 5-7 years to cap volatility ±8%
- Feedstock share: ~28% of COGS (2025 estimate)
- Priority: diversify suppliers across 3+ regions
2025: >35 g/L titers, 1,200 t/yr capacity, 60% carbon‑neutral feedstock, 12% marketing
EVERY Company advances yeast titers to >35 g/L by 2025 (each 1 g/L ≈1.7% COGS/kg reduction), operates partner DSP to >95% purity, audited 6 sites supporting 1,200 t/yr, spends 12% of 2025 revenue on marketing, secured 60% carbon-neutral feedstock (5-7yr contracts), feedstock ≈28% of COGS.
| Metric | 2025 Value |
|---|---|
| Target titer | >35 g/L |
| Audited partner sites | 6 |
| Finished capacity | 1,200 t/yr |
| Marketing spend | 12% rev |
| Feedstock mix | 60% carbon-neutral |
| Feedstock share of COGS | ≈28% |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual EVERY Company Business Model Canvas-not a mockup or sample-and it's exactly the same file you'll receive after purchase.
When you complete your order, you'll instantly get this full, ready-to-edit document in Word and Excel formats, structured and formatted exactly as shown.
